|
Real-time Estimate
Cboe Europe
07:51:20 02/10/26 pm AEST
|
5-day change | 1st Jan Change | ||
| 67.20 CHF | -0.88% |
|
-1.75% | +23.40% |
| 14/09 | Japanese Stocks Fall on AI Development Slowdown Calls; Oil Gains | MT |
| 14/09 | Asahi Kasei Unit Starts Phase Two Study of Antifungal Cresemba for Pediatric Patients in Japan | MT |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -0.88% | -1.75% | +2.74% | +27.12% | +23.40% | +40.04% | +60.33% | +57.56% | -12.51% | 1.01B | |
| +4.16% | +3.04% | +8.38% | +33.66% | +84.62% | +49.37% | +94.17% | +9.52% | - | 74.41B | |
| -0.93% | -1.35% | -7.42% | +1.04% | +16.32% | +24.67% | +78.54% | +225.20% | +5,410.91% | 59.26B | |
| +1.09% | -0.39% | -2.81% | +0.43% | +5.43% | +4.54% | +34.84% | -17.85% | +204.02% | 47.14B | |
| -3.02% | -5.20% | +0.92% | +28.31% | +15.66% | +27.94% | +32.51% | +7.94% | +221.64% | 42.91B | |
| +0.31% | +3.02% | -1.90% | +9.80% | +158.49% | +348.95% | +643.82% | +607.04% | - | 44.13B | |
| -1.96% | -0.33% | +0.03% | +23.40% | +18.09% | +7.04% | +99.46% | +0.58% | +1,064.46% | 40.79B | |
| +3.32% | +3.49% | -2.34% | +5.21% | +6.51% | +10.10% | +51.23% | -9.95% | +145.56% | 30.77B | |
| -2.68% | +2.92% | +10.78% | +52.12% | +73.51% | +29.63% | +22.72% | -52.81% | - | 29.31B | |
| -4.86% | -10.66% | -10.63% | +1.49% | -37.61% | -26.27% | +330.06% | +296.60% | +647.87% | 23.71B | |
| -1.48% | -2.43% | -5.00% | +3.12% | +1.73% | -5.24% | -10.85% | -61.99% | - | 24.33B | |
| -0.52% | +0.79% | +5.52% | +22.47% | +13.22% | +13.33% | -6.10% | -15.72% | +100.96% | 20.81B | |
| -4.18% | -3.63% | +2.55% | +10.03% | +6.49% | +9.96% | +147.01% | +205.72% | +1,902.95% | 16.69B | |
| -3.70% | +1.30% | -10.69% | -4.57% | +176.14% | +132.17% | +328.65% | +1,700.34% | +638.60% | 15.17B | |
| -0.23% | -1.47% | -12.66% | -15.12% | - | - | - | - | - | 14.93B | |
| -3.04% | +1.11% | -4.22% | +0.98% | +20.40% | -16.05% | +500.76% | - | - | 14.84B | |
| -0.03% | -3.67% | +2.39% | +7.78% | +19.42% | +18.59% | +42.38% | -28.87% | +81.05% | 14.57B | |
| -6.59% | -6.98% | +22.85% | +24.19% | +29.55% | -13.06% | - | - | - | 13.8B | |
| -0.80% | -0.02% | +1.85% | +7.38% | +32.19% | +40.63% | +165.17% | +168.99% | +353.01% | 14.36B | |
| -2.77% | -2.58% | +1.59% | +25.20% | +43.79% | +68.25% | +46.36% | -31.16% | +244.17% | 13.69B | |
| Average | -1.05% | -1.27% | +0.10% | +13.20% | +37.23% | +40.24% | +147.84% | +180.07% | +846.36% | 27.83B | |
| Weighted average by Cap. | -0.42% | -0.74% | +0.04% | +14.85% | +41.65% | +48.96% | +142.83% | +145.35% | +1,338.14% |
- Stock Market
- Stocks
- BSLN Stock
- Sector Basilea Pharmaceutica AG
Select your edition
All financial news and data tailored to specific country editions
